![Walter Schmidt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Walter Schmidt
Plus aucun poste en cours
Provenance du réseau au premier degré de Walter Schmidt
Entité | Type d'entité | Industrie | |
---|---|---|---|
Boehringer Ingelheim GmbH
![]() Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Max-Planck-Institute for Molecular Genetics
3
| College/University | Other Consumer Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Walter Schmidt via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
SSP Co., Ltd.
![]() SSP Co., Ltd. Pharmaceuticals: MajorHealth Technology SSP Co., Ltd. engages in the manufacture and sale of pharmaceuticals, quasi-drugs and cosmetics. The company was founded in 1765 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Macalester College | College/University | Undergraduate Degree | |
AS LATVIJAS GAZE | Gas Distributors | Director/Board Member | |
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Cardior Pharmaceuticals GmbH
![]() Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree | |
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Pcovery ApS
![]() Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Boehringer Ingelheim (Venture Capital)
![]() Boehringer Ingelheim (Venture Capital) Investment ManagersFinance Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Boehringer Ingelheim Pharmaceuticals, Inc.
![]() Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | President | |
UB4/BB GmbH & Co. KG
![]() UB4/BB GmbH & Co. KG Financial ConglomeratesFinance UB4/BB GmbH & Co. KG provides financial services. The private company is based in Ingelheim am Rhein, Germany. The German company was founded in 2001. The CEO is Christoph Gauger. | Financial Conglomerates | Chief Executive Officer | |
Boehringer Ingelheim Stiftung GmbH
![]() Boehringer Ingelheim Stiftung GmbH Investment Trusts/Mutual FundsMiscellaneous Boehringer Ingelheim Stiftung GmbH is a German company that engages in promoting scientific research and development. The private company is based in Ingelheim am Rhein, Germany. The company was founded in 1992. The CEO is Christoph Gauger. | Investment Trusts/Mutual Funds | Chief Executive Officer | |
Nippon Boehringer Ingelheim Co., Ltd.
![]() Nippon Boehringer Ingelheim Co., Ltd. Pharmaceuticals: MajorHealth Technology Established in 1961, Nippon Boehringer Ingelheim Co., Ltd. develops, manufactures, imports and markets pharmaceutical products. The company is also involved in the importation and exportation of intermediates and bulk pharmaceutical products. Nippon Boehringer Ingelheim is based in Tokyo and operates in several parts of Japan through its domestic offices. | Pharmaceuticals: Major | Director of Finance/CFO | |
Boehringer Ingelheim Japan Investment GK
![]() Boehringer Ingelheim Japan Investment GK Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Japan Investment GK is an investment holding Japanese company. The company is based in Tokyo, Japan. | Financial Conglomerates | President | |
Bayer Pharma AG
![]() Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Bonn | College/University | Doctorate Degree | |
Karolinska Institutet | College/University | Corporate Officer/Principal | |
Bernhard-Nocht-Institut für Tropenmedizin
![]() Bernhard-Nocht-Institut für Tropenmedizin Hospital/Nursing ManagementHealth Services The Bernhard-Nocht-Institut für Tropenmedizin is a research institute based in Hamburg, Germany. The institute focuses on tropical medicine and aims to minimize the risk of dangerous pathogens and toxins for everyone. The German company works with partner institutions in various countries to train laboratory staff and conduct research on diseases, diagnostics, and capacity strengthening. The institute also offers training courses, laboratory diagnostics, and information on travel and clinical research. | Hospital/Nursing Management | Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AFFiRiS AG
![]() AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Opterion Health AG
![]() Opterion Health AG Medical/Nursing ServicesHealth Services Opterion Health AG is a Swiss company that focuses on bringing innovation to dialysis care and fostering home dialysis to improve the quality of life for patients suffering from end-stage renal disease (ESRD). Opterion Health is based in Muttenz, CH. The private company aims to increase the survival rates of people with ESRD and reduce healthcare costs. The company was founded in 2012 by Guido Grentzmann, and the CEO is Bjorn Englund. | Medical/Nursing Services | Chief Executive Officer | |
Bayer CropScience AG
![]() Bayer CropScience AG Chemicals: AgriculturalProcess Industries Bayer CropScience AG manufactures and distributes pesticides, and vegetable seeds. Its products include crops such as cotton, fruits and vegetables, oil seeds and wheat, brands includes fungicides, herbicides and seeds growth. The company was founded in 1979 and is headquartered In Monheim am Rhein, Germany. | Chemicals: Agricultural | Corporate Officer/Principal | |
Bayer HealthCare Pharmaceuticals, Inc.
![]() Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Proteros biostructures GmbH
![]() Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Medical/Nursing Services | Public Communications Contact | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | ||
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiques
Internationale
Allemagne | 13 |
Etats-Unis | 8 |
Japon | 4 |
Belgique | 3 |
Suisse | 3 |
Sectorielle
Health Technology | 14 |
Consumer Services | 5 |
Health Services | 5 |
Finance | 4 |
Utilities | 3 |
Opérationnelle
Corporate Officer/Principal | 15 |
Director/Board Member | 9 |
Doctorate Degree | 5 |
Chief Tech/Sci/R&D Officer | 4 |
Chief Executive Officer | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Walter Schmidt
- Connexions Sociétés